1. Home
  2. SHPH
  3. SHPH News

Latest Shuttle Pharmaceuticals Holdings Inc. (SHPH) News on January 19, 2025

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
SHPH

GlobeNewswire

12 days ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
SHPH

GlobeNewswire

a month ago

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
SHPH

GlobeNewswire

2 months ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Shuttle Pharma Provides Third Quarter 2024 Corporate Update
SHPH

GlobeNewswire

2 months ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
SHPH

GlobeNewswire

3 months ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Shuttle Pharma Pays Off Senior Secured Convertible Note
SHPH

GlobeNewswire

3 months ago

Shuttle Pharma Pays Off Senior Secured Convertible Note

Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
SHPH

GlobeNewswire

3 months ago

Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
SHPH

GlobeNewswire

3 months ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
SHPH

GlobeNewswire

3 months ago

Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024

SHPH

MT Newswires

4 months ago

Shuttle Pharmaceuticals Launches Equity Offering

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
SHPH

GlobeNewswire

4 months ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
SHPH

ACCESSWIRE

4 months ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
SHPH

GlobeNewswire

4 months ago

Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease

Shuttle Pharma Provides Second Quarter 2024 Corporate Update
SHPH

GlobeNewswire

4 months ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

SHPH

MT Newswires

5 months ago

Shuttle Pharmaceuticals Regains Nasdaq Compliance

Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
SHPH

GlobeNewswire

5 months ago

Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)
SHPH

GlobeNewswire

5 months ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
SHPH

GlobeNewswire

5 months ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
SHPH

GlobeNewswire

6 months ago

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

SHPH

MT Newswires

7 months ago

Shuttle Pharmaceuticals Names Timothy Lorber as Chief Financial Officer

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
SHPH

GlobeNewswire

7 months ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
SHPH

GlobeNewswire

8 months ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Shuttle Pharma Provides First Quarter 2024 Corporate Update
SHPH

GlobeNewswire

8 months ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

SHPH

ACCESSWIRE

9 months ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
SHPH

GlobeNewswire

9 months ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
SHPH

GlobeNewswire

10 months ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
SHPH

GlobeNewswire

10 months ago

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
SHPH

PR Newswire

10 months ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
SHPH

GlobeNewswire

10 months ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
SHPH

GlobeNewswire

10 months ago

Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
SHPH

PR Newswire

a year ago

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
SHPH

GlobeNewswire

a year ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Golden Sun Education Group Limited Schedules Press Conference to Announce Strategic Transformation on January 26, 2024, in Wenzhou, Zhejiang Province
SHPH

GlobeNewswire

a year ago

Golden Sun Education Group Limited Schedules Press Conference to Announce Strategic Transformation on January 26, 2024, in Wenzhou, Zhejiang Province

NAVIGATING TOMORROW: Japan Airlines Cargo Chooses WebCargo for Global Digital Expansion
SHPH

PR Newswire

a year ago

NAVIGATING TOMORROW: Japan Airlines Cargo Chooses WebCargo for Global Digital Expansion

Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
SHPH

PR Newswire

a year ago

Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
SHPH

PR Newswire

a year ago

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

CURO to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 7, 2024
SHPH

Business Wire

a year ago

CURO to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 7, 2024

IBN Coverage Initiated for Astrotech Corp.
SHPH

GlobeNewswire

a year ago

IBN Coverage Initiated for Astrotech Corp.

SHPH

Business Wire

a year ago

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Transforming Challenges into Triumphs: HUB Anticipates a Strong 2024-2025
SHPH

GlobeNewswire

a year ago

Transforming Challenges into Triumphs: HUB Anticipates a Strong 2024-2025

Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
SHPH

PR Newswire

a year ago

Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

SHPH

Business Wire

a year ago

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Stronghold Digital Mining Inc CEO Gregory Beard Sells 38,759 Shares
SHPH

GuruFocus.com

a year ago

Stronghold Digital Mining Inc CEO Gregory Beard Sells 38,759 Shares

Akoustis Receives Wi-Fi 6E Design Win from Tier-1 Consumer AP Customer
SHPH

GlobeNewswire

a year ago

Akoustis Receives Wi-Fi 6E Design Win from Tier-1 Consumer AP Customer

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Stock Rockets 26% But Many Are Still Ignoring The Company
SHPH

Simply Wall St.

a year ago

Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Stock Rockets 26% But Many Are Still Ignoring The Company

SHPH

Thomson Reuters StreetEvents

a year ago

Q3 2023 Streamline Health Solutions Inc Earnings Call

Real Good Foods Announces Expansion of its Nutritious Burritos into the Refrigerated Category in Club Stores Nationwide & Select Walmart Stores
SHPH

GlobeNewswire

a year ago

Real Good Foods Announces Expansion of its Nutritious Burritos into the Refrigerated Category in Club Stores Nationwide & Select Walmart Stores

Life Science Investor Forum Agenda Announced for December 14th, 2023
SHPH

GlobeNewswire

a year ago

Life Science Investor Forum Agenda Announced for December 14th, 2023

OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?
SHPH

Zacks

a year ago

OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?

Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma
SHPH

PR Newswire

a year ago

Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

OFS Credit Company Announces Financial Results for the Fourth Fiscal Quarter 2023
SHPH

Business Wire

a year ago

OFS Credit Company Announces Financial Results for the Fourth Fiscal Quarter 2023

Gorilla Technology Group Announces Business Update
SHPH

GlobeNewswire

a year ago

Gorilla Technology Group Announces Business Update

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea
SHPH

GlobeNewswire

a year ago

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
SHPH

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Xcel Brands, Inc. to Present at Upcoming Investor Conferences
SHPH

GlobeNewswire

a year ago

Xcel Brands, Inc. to Present at Upcoming Investor Conferences

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023
SHPH

PR Newswire

a year ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023

11 Best Cannabis Stocks To Buy Now
SHPH

Insider Monkey

a year ago

11 Best Cannabis Stocks To Buy Now

REE Automotive, Ltd. Announces Date for Third Quarter 2023 Earnings Release and Conference Call
SHPH

GlobeNewswire

a year ago

REE Automotive, Ltd. Announces Date for Third Quarter 2023 Earnings Release and Conference Call

Westwater Resources Announces Q3 2023 Business and Financial Updates
SHPH

Business Wire

a year ago

Westwater Resources Announces Q3 2023 Business and Financial Updates

SHPH

Thomson Reuters StreetEvents

a year ago

Q1 2024 Palatin Technologies Inc Earnings Call

SHPH

Business Wire

a year ago

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

BowFlex Inc. Reports Second Quarter Fiscal 2024 Results
SHPH

Business Wire

a year ago

BowFlex Inc. Reports Second Quarter Fiscal 2024 Results

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update
SHPH

PR Newswire

a year ago

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Lags Revenue Estimates
SHPH

Zacks

a year ago

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Lags Revenue Estimates

Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results
SHPH

GlobeNewswire

a year ago

Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Q3 2023 Earnings Call Transcript
SHPH

Insider Monkey

a year ago

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Q3 2023 Earnings Call Transcript

Research Solutions to Participate in Pair of Investor Conferences
SHPH

PR Newswire

a year ago

Research Solutions to Participate in Pair of Investor Conferences

SHPH

PR Newswire

a year ago

Willamette Valley Vineyards Announces Annual Cash Dividend for Series A Redeemable Preferred Stock

Airspan Networks Holdings Inc. Reports Third Quarter 2023 Results
SHPH

Business Wire

a year ago

Airspan Networks Holdings Inc. Reports Third Quarter 2023 Results

Nephros Hires Judy Krandel as Chief Financial Officer
SHPH

GlobeNewswire

a year ago

Nephros Hires Judy Krandel as Chief Financial Officer

Share on Social Networks: